Assessment of Device-Related Thrombus and Associated Clinical Outcomes With the WATCHMAN Left Atrial Appendage Closure Device for Embolic Protection in Patients With Atrial Fibrillation (from the PROTECT-AF Trial).

[1]  Saibal Kar,et al.  Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. , 2014, JAMA.

[2]  R. Erbel,et al.  Risk factors for thrombus formation on the Amplatzer Cardiac Plug after left atrial appendage occlusion. , 2013, JACC. Cardiovascular interventions.

[3]  A. Meijer,et al.  Thrombus formation on an Amplatzer closure device after left atrial appendage closure. , 2013, European heart journal.

[4]  P. Neužil,et al.  Percutaneous Left Atrial Appendage Closure for Stroke Prophylaxis in Patients With Atrial Fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients With Atrial Fibrillation) Trial , 2013, Circulation.

[5]  A. Yilmaz,et al.  Incomplete Endothelialization of Left Atrial Appendage Occlusion Device 10 Months After Implantation , 2012, Journal of cardiovascular electrophysiology.

[6]  M. Gasparini,et al.  Huge left atrial thrombus after left atrial appendage occlusion with a Watchman device. , 2012, European heart journal.

[7]  I. Cruz-González,et al.  Thrombus formation after left atrial appendage exclusion using an amplatzer cardiac plug device , 2011, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[8]  A. Leal,et al.  Thrombus formation on a left atrial appendage closure device. , 2011, Circulation.

[9]  Saibal Kar,et al.  Safety of Percutaneous Left Atrial Appendage Closure: Results From the Watchman Left Atrial Appendage System for Embolic Protection in Patients With AF (PROTECT AF) Clinical Trial and the Continued Access Registry , 2011, Circulation.

[10]  R. Virmani,et al.  Left atrial appendage obliteration: mechanisms of healing and intracardiac integration. , 2010, JACC. Cardiovascular interventions.

[11]  Maurice Buchbinder,et al.  Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial , 2009, The Lancet.

[12]  Pamela S Douglas,et al.  Echocardiographic Imaging in Clinical Trials: American Society of Echocardiography Standards for Echocardiography Core Laboratories Endorsed by the American College of Cardiology Foundation , 2022 .

[13]  M. Main,et al.  Transesophageal echocardiographic diagnosis of left atrial appendage occluder device infection. , 2007, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[14]  D. Packer,et al.  The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients with Atrial Fibrillation) trial. , 2006, American heart journal.

[15]  J. Gardin,et al.  American Society of Echocardiography recommendations for use of echocardiography in clinical trials. , 2004, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[16]  W. Manning,et al.  Accuracy of Transesophageal Echocardiography for Identifying Left Atrial Thrombi: A Prospective, Intraoperative Study , 1995, Annals of Internal Medicine.

[17]  D. Fatkin,et al.  Left atrial appendage blood velocity and thromboembolic risk in patients with atrial fibrillation. , 1994, Journal of the American College of Cardiology.

[18]  D. Leung,et al.  Prognostic implications of left atrial spontaneous echo contrast in nonvalvular atrial fibrillation. , 1994, Journal of the American College of Cardiology.

[19]  D. Fatkin,et al.  Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo. , 1994, Journal of the American College of Cardiology.

[20]  R. Poole,et al.  Left Atrial Spontaneous Echo Contrast Is Highly Associated With Previous Stroke in Patients With Atrial Fibrillation or Mitral Stenosis , 1993, Stroke.

[21]  Tsai Liang-Miin,et al.  Clinical implications of left atrial spontaneous echo contrast in nonrheumatic atrial fibrillation. , 1992 .

[22]  S. Beppu,et al.  Smoke-like echo in the left atrial cavity in mitral valve disease: its features and significance. , 1985, Journal of the American College of Cardiology.